title: Measles seropositivity in HIV-infected Kenyan children on antiretroviral therapy.
abstract: This article describes results from a cross-sectional study among HIV-infected children 15 months to 12 years of age who were receiving antiretroviral therapy. We found a low prevalence of measles IgG seropositivity (45.7%) and identified CD4% ≥ 25 as a predictor. Most HIV-infected children on ART were not measles seropositive and might benefit from revaccination.
authors.affiliation: From the *Department of Epidemiology, University of Washington, Seattle, WA; †Department of Public Health, University of Nairobi, Nairobi, Kenya; ‡Department of Medicine, University of Washington, Seattle, WA: §Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya; Departments of ¶Global Health and ‖Biostatistics, University of Washington; and **Division of Vaccine and Infectious Disease, Fred Hutchinson Cancer Research Center, Seattle, WA.
authors.forename: Laura P
authors.initials: LP
authors.lastname: Newman
authors.forename: Anne
authors.initials: A
authors.lastname: Njoroge
authors.forename: Leila
authors.initials: L
authors.lastname: Ben-Youssef
authors.forename: Michele
authors.initials: M
authors.lastname: Merkel
authors.forename: Ann
authors.initials: A
authors.lastname: Gatuguta
authors.forename: Quy
authors.initials: Q
authors.lastname: Ton
authors.forename: Elizabeth Maleche
authors.initials: EM
authors.lastname: Obimbo
authors.forename: Dalton
authors.initials: D
authors.lastname: Wamalwa
authors.forename: Barbara
authors.initials: B
authors.lastname: Lohman-Payne
authors.forename: Barbra A
authors.initials: BA
authors.lastname: Richardson
authors.forename: Ruth
authors.initials: R
authors.lastname: Nduati
authors.forename: Carey
authors.initials: C
authors.lastname: Farquhar
mesh_terms: D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D000914:Antibodies, Viral / Q000097:blood*; D018791:CD4 Lymphocyte Count; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology / Q000821:virology*; D015528:HIV Seroprevalence; D006801:Humans; D007223:Infant; D007630:Kenya / Q000453:epidemiology; D008297:Male; D008457:Measles / Q000453:epidemiology / Q000276:immunology / Q000821:virology*; D008458:Measles Vaccine / Q000008:administration & dosage
chemical_list: D044966:Anti-Retroviral Agents; D000914:Antibodies, Viral; D008458:Measles Vaccine